Recent Company News

• 10:42 AM ET Aug 05, 2026
  

  Epilepsia Open publishes results of post hoc data analysis of FINTEPLA (fenfluramine) in patients with Lennox-Gastaut syndrome (€230.10, +6.80)

• 04:42 AM ET Jul 30, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:06 AM ET Aug 03, 2026
  

  UCB upgraded to hold from underperform at Jefferies (€222.90, 0.00)

• 09:00 AM ET Jul 30, 2026
  

  Transcript Intelligence: UCB Q2 Earnings Guidance

• 09:00 AM ET Jul 30, 2026
  

  Transcript Intelligence: UCB Q2 Earnings Themes

• 09:00 AM ET Jul 30, 2026
  

  Transcript Intelligence: UCB Q2 Earnings Q&A

• 07:58 AM ET Jul 30, 2026
  

  Basic Resources and Construction & Materials lead; Health Care, Telecom and Personal & Household Goods lag:

• 02:59 AM ET Jul 30, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:14 AM ET Jul 30, 2026
  

  StreetAccount Metrics Recap - UCB H1 Earnings (€250.90, 0.00)